这是附加信息
Description
CJC-1295 with DAC is a synthetic modified peptide compound engineered for laboratory research. The molecule features a Drug Affinity Complex (DAC) modification that enhances its stability in experimental conditions. Laboratory research demonstrates specific molecular pathway interactions and distinct binding properties in controlled models. The compound is designed with a 30-amino acid sequence structure, showing selective receptor affinity in vitro studies. The DAC modification allows for extended stability in solution compared to the non-modified variant, making it particularly suitable for prolonged laboratory studies.
Sustained Signaling Pathway: "Designed for research into prolonged GHRH receptor activation with a significantly extended biological half-life."
Experimental Consistency: "Ideal for longitudinal studies requiring stable plasma concentrations and reduced variance in metabolic data."
99% Synthesis Fidelity: "Individual batch HPLC verification ensuring 99.2% purity for reliable binding affinity in chronic modeling."
Properties
- Molecular Code: CWD-5 / GHRH-DAC Analog
- Half-Life: Extended (6 - 8 days approx. for research models).
- Purity: ≥ 99.2% (HPLC Verified)
- Research Focus: Chronic GH axis elevation, long-term lipid metabolism, and systemic homeostasis.
You have successfully commented, please wait for review
Copied Successfully
You can enjoy up to 1 free gift!